Skip Navigation


Rheumatology Advance Access originally published online on September 1, 2004
Rheumatology 2004 43(12):1536-1540; doi:10.1093/rheumatology/keh376
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary data
Right arrow All Versions of this Article:
43/12/1536    most recent
keh376v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Khanna, S.
Right arrow Articles by Handa, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khanna, S.
Right arrow Articles by Handa, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology Vol. 43 No. 12 © British Society for Rheumatology 2004; all rights reserved

PAPER

The relationship between disease activity and quality of life in systemic lupus erythematosus

S. Khanna1, H. Pal2, R. M. Pandey3 and R. Handa1

1 Department of Medicine, 2 Department of Psychiatry and 3 Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.

Correspondence to: R. Handa. E-mail: rohinihanda{at}hotmail.com

Objective. To determine the quality of life (QOL) in SLE patients and correlate it with disease activity.

Methods. Lupus patients fulfilling the ACR 1997 criteria for SLE were included in this cross-sectional study. Patients were administered the World Health Organization Quality of Life—Bref (WHOQOL-Bref) to assess their quality of life. Disease activity was measured using Mexican Systemic Lupus Erythematosus Disease Activity Index (Mex-SLEDAI).

Results. The study group comprised 73 lupus patients (70 females and three males) with mean age 35.22 ± 11.15 yr and mean disease duration 5.62 ± 5.14 yr. Mean Mex-SLEDAI score was 3.31 ± 3.19. Higher disease activity scores were associated with lower QOL scores in the physical (P = 0.001) and psychological domains (P = 0.01) but showed no significant correlation with the domains of social and environmental QOL. Patients with clearly active and probably active disease showed significantly lower scores in the physical (P = 0.01) and psychological (P = 0.02) domains than patients with inactive disease. However, no significant difference was found in the domains of social and environmental QOL. Age or disease duration did not affect the QOL in any of the domains.

Conclusions. Physical and psychological QOL are impaired to a larger extent in active lupus. However, social and environmental QOL do not correlate with the disease activity status in lupus patients.

KEY WORDS: SLE, Disease activity, Quality of life, Mex-SLEDAI, WHOQOL


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
L. Moorthy, M. Peterson, M. Harrison, K. Onel, and T. Lehman
Review: Quality of life in children with systemic lupus erythematosus: a review
Lupus, August 1, 2007; 16(8): 663 - 669.
[Abstract] [PDF]

Home page
 Ann Rheum DisHome page
A M Bertoli, M Fernandez, G S Alarcon, L M Vila, J D Reveille, and for the LUMINA Study Group
Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability
Ann Rheum Dis, January 1, 2007; 66(1): 12 - 17.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
K Mcelhone, J Abbott, and L -S Teh
A review of health related quality of life in systemic lupus erythematosus
Lupus, October 1, 2006; 15(10): 633 - 643.
[Abstract] [PDF]

Home page
 LupusHome page
M Abu-Shakra, A Keren, I Livshitz, V Delbar, A Bolotin, S Sukenik, and Y Kanat-Maymon
Sense of coherence and its impact on quality of life of patients with systemic lupus erythematosus
Lupus, January 1, 2006; 15(1): 32 - 37.
[Abstract] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.